Recent News

By Region: North America

Salmonella uses protective switch during infection

(EurekAlert) For the first time, researchers have found a particular kind of molecular switch in the food poisoning bacteria Salmonella Typhimurium under infection-like conditions. This switch, using a process called S-thiolation, appears to be used by the bacteria to respond to changes in the environment during infection and might protect it from harm, researchers report  Read More »

Reports of PED in the U.S. Prompt Calls for Steped Up Biosecurity

(Farmscape) The Canadian Swine Health Board is advising Canadian pork producers to step up their focus on biosecurity in the wake of reports of possible outbreaks of Porcine Epidemic Diarrhea in the U.S. Possible outbreaks of Porcine Epidemic Diarrhea, a viral disease that causes severe watery diarrhea in pigs resulting in high morbidity in sows  Read More »

Anthrax drug brings $334 million to Pentagon advisor’s biotech firm

(TimesRecordNews) Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a major threat to national security. Terrorists, he warned, could easily engineer a devastating killer germ: a form  Read More »

Custom flu vaccine developed in a week by synthetic biologists

(DVICE) According to the CDC, not only did the 2012-2013 flu season begin early, but activity of the virus was considered high. Also, the vaccines for that season were only shown to be only around 56% effective in preventing flu-related doctors’ visits. This is a result of the flu virus changing so quickly as it  Read More »

BARDA Partners with GSK for Hospital and Biothreat Antibacterials

(GlobalBiodefense) The U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has entered into a collaborative agreement with Glaxo Smith Kline (GSK) to evaluate the efficacy and safety of the company’s portfolio of clinical stage antibacterial assets for treating hospital and biothreat infections. The contract is unique in that it  Read More »

« First...102030...9192939495...100110120...Last »

Also filed under "North America":